QSV Equity Investors LLC boosted its position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 34.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,786 shares of the company's stock after purchasing an additional 10,190 shares during the quarter. QSV Equity Investors LLC owned about 0.07% of Astrana Health worth $1,234,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also bought and sold shares of ASTH. Quarry LP lifted its stake in Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares in the last quarter. Covestor Ltd lifted its stake in Astrana Health by 777.6% in the 1st quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares in the last quarter. US Bancorp DE lifted its stake in Astrana Health by 21.3% in the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after purchasing an additional 1,015 shares in the last quarter. PharVision Advisers LLC purchased a new stake in Astrana Health in the 4th quarter worth approximately $211,000. Finally, Envestnet Asset Management Inc. lifted its stake in Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock worth $225,000 after purchasing an additional 1,184 shares in the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.
Astrana Health Price Performance
NASDAQ ASTH traded up $0.71 on Friday, hitting $30.68. The stock had a trading volume of 347,033 shares, compared to its average volume of 511,003. Astrana Health, Inc. has a 52-week low of $21.20 and a 52-week high of $63.20. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59. The company has a market capitalization of $1.72 billion, a price-to-earnings ratio of 60.16, a price-to-earnings-growth ratio of 0.74 and a beta of 0.85. The firm has a 50-day moving average of $25.26 and a 200-day moving average of $28.67.
Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The firm had revenue of $654.81 million during the quarter, compared to analysts' expectations of $639.13 million. During the same quarter in the prior year, the company earned $0.40 earnings per share. The business's revenue for the quarter was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. Equities analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current year.
Astrana Health Profile
(
Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
See Also

Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.